So he took his a fraction of his 10% divined, and
Post# of 154094
(Total Views: 470)
Posted On: 11/01/2019 1:34:27 PM
Re: the lawman #10365
So he took his a fraction of his 10% divined, and bought shares and that is impressive?
You will never convince me about NP's lack of investment here. He has half his salary deferred in stock options, his credibility and life's work is tied up into getting leronlimab to the finish line. He is fully invested!
Now, I'm surprised on a day that NP missed a miss big deadline you would focus on this. Surely you would have a better argument focusing on NP's performance and not questioning NP's investment or if he believes in the company. He is putting his own mother-in-law with stage 4 cancer on leronlimab for pete's sake; her life is literally on the line. You don't think he believes in leronlimab or cydy?
Here is a better argument for you:
golden quarter
no more fund raising after the TO
deal in two weeks
BLA by end of September
financing with paulson, selling shares risk free warrants
convertible financing with fife
R/S announced then canceled after realizing raising cash terms too high
Say all that, then say, if he misses the BLA timeline by end of year and the deal doesn't get done, then he should be replaced. You will get lots of support. Beating the dead horse no investment isn't going to get you anywhere.
My opinion:
Are there better CEOs? yeah. Are there better CEOs on OTC? rare
Will he be replaced? No, never on otc.
Why I don't focus on NP? Wasted cause. Wasted effort. I don't invest in companies I think would be great if the CEO was replaced. I look to see if the current CEO can get it done. Will all his flaws, I think he gets us to approval or I wouldn't be here. Once the company doesn't need to sell shares to continue and can use revenue, it will be a game changer. I see lots of pre-revenue biotech, nasdaq even, tanking worse than cydy over time. Getting drug approval changes that and we are inching closer and closer to the finish line, I'm betting NP gets us there. Again, if I thought it would take another ceo to gets us there, I would be gone.
You will never convince me about NP's lack of investment here. He has half his salary deferred in stock options, his credibility and life's work is tied up into getting leronlimab to the finish line. He is fully invested!
Now, I'm surprised on a day that NP missed a miss big deadline you would focus on this. Surely you would have a better argument focusing on NP's performance and not questioning NP's investment or if he believes in the company. He is putting his own mother-in-law with stage 4 cancer on leronlimab for pete's sake; her life is literally on the line. You don't think he believes in leronlimab or cydy?
Here is a better argument for you:
golden quarter
no more fund raising after the TO
deal in two weeks
BLA by end of September
financing with paulson, selling shares risk free warrants
convertible financing with fife
R/S announced then canceled after realizing raising cash terms too high
Say all that, then say, if he misses the BLA timeline by end of year and the deal doesn't get done, then he should be replaced. You will get lots of support. Beating the dead horse no investment isn't going to get you anywhere.
My opinion:
Are there better CEOs? yeah. Are there better CEOs on OTC? rare
Will he be replaced? No, never on otc.
Why I don't focus on NP? Wasted cause. Wasted effort. I don't invest in companies I think would be great if the CEO was replaced. I look to see if the current CEO can get it done. Will all his flaws, I think he gets us to approval or I wouldn't be here. Once the company doesn't need to sell shares to continue and can use revenue, it will be a game changer. I see lots of pre-revenue biotech, nasdaq even, tanking worse than cydy over time. Getting drug approval changes that and we are inching closer and closer to the finish line, I'm betting NP gets us there. Again, if I thought it would take another ceo to gets us there, I would be gone.
(8)
(0)